Related Experiment Video
Updated: May 28, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Infantile hypophosphatasia: a rare aetiology of recurrent pneumonia
Nikita Diwan1, Areesha Alam2, Nishant Verma2
1Department of Paediatrics, King George's Medical College, Lucknow, Uttar Pradesh, India angelsanddemons.nik@gmail.com.
Abstract:
We report a rare case of infantile hypophosphatasia associated with recurrent pneumonia, a condition with few similar cases documented globally. Clinical exome sequencing identified a heterozygous mutation in the alkaline phosphatase (ALPL) gene (c.69_74del; p.Glu23_Lys24del), the first such case reported in India and classified as 'likely pathogenic'. Its causality remains unproven due to limited evidence, including the absence of in vitro studies and pedigree analysis. Phenotypic variability may be influenced by factors such as incomplete penetrance, variable expressivity and environmental or epigenetic modifiers. This case highlights a rare but important cause of recurrent pneumonia in infants. Despite treatment, the child succumbed to severe pneumonia within 2 months. Clinicians should consider infantile hypophosphatasia in cases of recurrent pneumonia, motor delay, seizures, severe malnutrition and persistently low serum alkaline phosphatase. Further genetic and functional studies are needed to validate genotype-phenotype correlations and improve disease management.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Inborn Errors of Metabolism